Results 81 to 90 of about 12,750 (218)

Short-term predictive value of sST2 in patients with STEMI following primary PCI: a prospective observational study

BMC Cardiovascular Disorders
Aim The objective of this study was to investigate the level of soluble suppression of tumorigenicity-2 (sST2) in patients with acute ST-segment elevation myocardial infarction (STEMI) following primary percutaneous coronary intervention (PCI), and to ...
Shan Huang, Lu-Jiao Yu, Guang-Feng Sun, Zi-Xin Zhang   +3 more
doaj   +1 more source

Hyperglycemia induced by pasireotide in patients with Cushing’s disease or acromegaly [PDF]

, 2016
PURPOSE: Cushing’s disease (CD) and acromegaly are characterized by excessive hormone secretion resulting in comorbidities such as impaired glucose metabolism, diabetes and hypertension.
Silverstein, Julie M
core   +2 more sources

IL-33 (Interleukin 33)/sST2 Axis in Hypertension and Heart Failure [PDF]

Hypertension, 2018
IL-33 (interleukin 33) is type of cytokine designated an alarmin, which is released under stress conditions or by cell death to induce protective measures in neighboring cells.1 It signals via the ST2 (suppression of tumorigenicity 2) receptor, which is also expressed as a truncated and soluble form that acts as a decoy receptor soluble ST2 (sST2).2 ...
Ghali, Rana, Altara, Raffaele, Louch, William E, Cataliotti, Alessandro, Mallat, Ziad, Kaplan, Abdullah, Zouein, Fouad A, Booz, George W   +7 more
openaire   +2 more sources

Are soluble ST2 levels influenced by vitamin D and/or the seasons?

Endocrine Connections, 2019
Objective: Cardiovascular disease manifestation and several associated surrogate markers, such as vitamin D, have shown substantial seasonal variation.
Vito Francic, Martin Keppel, Verena Schwetz, Christian Trummer, Marlene Pandis, Valentin Borzan, Martin R Grübler, Nicolas D Verheyen, Marcus E Kleber, Graciela Delgado, Angela P Moissl, Benjamin Dieplinger, Winfried März, Andreas Tomaschitz, Stefan Pilz, Barbara Obermayer-Pietsch   +15 more
doaj   +1 more source

Somatostatin analogues for receptor targeted photodynamic therapy [PDF]

, 2014
Photodynamic therapy (PDT) is an established treatment modality, used mainly for anticancer therapy that relies on the interaction of photosensitizer, light and oxygen.
Achilefu, Samuel, Brugts, Michael P, De Bruijn, Henriette S, Hofland, Leo J, Kascakova, Slavka, Robinson, Dominic J, Strerenborg, Henricus J. C. M., ten Hagen, Timo L. M., van der Lelij, Aart-Jan, van der Ploeg-van den Heuvel, Angelique, van der Wansem, Katy, van Hagen, Martin P, van Koetsveld, Peter M, Ye, Yunpeng   +13 more
core   +9 more sources

Prognostic biomarker soluble ST2 exhibits diurnal variation in chronic heart failure patients

ESC Heart Failure, 2020
Aim Soluble suppression of tumorigenicity‐2 (sST2) is a strong prognostic biomarker in heart failure. The emerging understanding of circadian biology in cardiovascular disease may lead to novel applications in prognosis and diagnosis and may provide ...
Sandra Crnko, Markella I. Printezi, Tijn P.J. Jansen, Laurynas Leiteris, Manon G. van derMeer, Hilde Schutte, Martijn vanFaassen, Bastiaan C. duPré, Nicolaas deJonge, Folkert W. Asselbergs, Carlo A.J.M. Gaillard, Hans Kemperman, Pieter A. Doevendans, Joost P.G. Sluijter, Linda W. vanLaake   +14 more
doaj   +1 more source

Salivary IL ‐33 and sST2 levels in relation to TLR2 rs111200466 polymorphism and periodontitis [PDF]

, 2023
Mustafa Yılmaz, Qiushui He, Esra Demir, Johanna Teräsjärvi, Ulvi Kahraman Gürsoy   +4 more
openalex   +1 more source

Cardiac Biomarkers and Risk of Atrial Fibrillation in Chronic Kidney Disease: The CRIC Study. [PDF]

, 2019
Background We tested associations of cardiac biomarkers of myocardial stretch, injury, inflammation, and fibrosis with the risk of incident atrial fibrillation (AF) in a prospective study of chronic kidney disease patients.
Anderson, Amanda H, Appel, Lawrence J, Bansal, Nisha, Christenson, Rob, deFilippi, Christopher R, Deo, Rajat, Feldman, Harold I, Floyd, James S, Go, Alan S, He, Jiang, Kusek, John W, Ky, Bonnie, Lamprea‐Montealegre, Julio A, Lash, James P, Rahman, Mahboob, Rao, Panduranga S, Seliger, Stephen L, Shafi, Tariq, Shlipak, Michael G, Soliman, Elsayed Z, Townsend, Raymond R, Wolf, Myles S, Zelnick, Leila R   +22 more
core  

Association between soluble suppression of tumorigenicity 2 and risk and severity of coronary artery disease: a case control study

BMC Cardiovascular Disorders
Background To investigate the differential expression of soluble suppression of tumorigenicity 2 (sST2) in patients with coronary artery disease (CAD) and healthy controls, and the correlation between sST2 and the severity of coronary artery ...
Shuai Zhang, Lu Qian, Shibao Li, Zhijian Liu   +3 more
doaj   +1 more source

Assessment of combined serum sST2 and AFP levels in the diagnosis of hepatocellular carcinoma [PDF]

PeerJ
Background Hepatocellular carcinoma (HCC) is a common malignant tumor with high morbidity and mortality. Alpha-fetoprotein (AFP) is the most widely used diagnostic serum biomarker, but it still has limited accuracy in detecting HCC, suggesting the ...
Xiuxin Tang, Dong Wang, Tangdan Ding, Rongqi Lin, Meifang He, Ruizhi Wang, Liubing Li   +6 more
doaj   +2 more sources